Skip to main content

Table 4 Cox regression analysis of the effects of total cholesterol levels on dementia conversion

From: Differential effects of cholesterol levels on cognition according to body mass index in Parkinson’s disease

Variables

Model 1 (C-index = 0.791)

Model 2 (C-index = 0.793)

HR (95% CI)

P

HR (95% CI)

P

Age at symptom onset

1.063 (1.023–1.105)

0.002

1.068 (1.027–1.111)

0.001

Female

0.381 (0.188–0.771)

0.007

0.367 (0.183–0.736)

0.005

Symptom duration

1.003 (0.984–1.023)

0.736

1.001 (0.981–1.02)

0.958

Education

0.999 (0.933–1.070)

0.973

0.997 (0.931–1.066)

0.919

MMSE score

0.808 (0.710–0.919)

0.001

0.795 (0.695–0.909)

0.001

Hypertension

1.333 (0.725–2.449)

0.355

1.439 (0.782–2.649)

0.242

Diabetes

0.864 (0.442–1.687)

0.668

0.774 (0.392–1.527)

0.459

Statin use

1.513 (0.799–2.866)

0.204

1.489 (0.790–2.807)

0.218

DAT-PP

 WMHs burden

1.025 (0.991–1.061)

0.150

1.025 (0.991–1.061)

0.150

 BMI

0.930 (0.837–1.033)

0.177

0.977 (0.872–1.096)

0.696

 TC levels per 1 SD increase

0.863 (0.638–1.166)

0.336

0.015 (0.001–0.154)

 < 0.001

 BMI × TC levels

-

-

1.193 (1.0811.317)

 < 0.001

  1. Results of Cox regression analyses for PDD conversion after controlling for age at symptom onset, sex, symptom duration, years of education, MMSE scores, the presence of hypertension and diabetes, statin use, WMHs burden, BMI, TC levels, and/or the interaction term of BMI*TC levels
  2. BMI body mass index, CI confidence interval, DAT-PP dopamine transporter availability in the posterior putamen, HR hazard ratio, MMSE the Mini-Mental state Examination, TC total cholesterol, WMHs white matter hyperintensities